| Product Code: ETC11831755 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Burkina Faso`s import of cell gene therapy from CDMOs saw a substantial increase in 2024, with top exporting countries being the USA, Germany, Costa Rica, India, and France. The market concentration remained high, indicating a competitive landscape among suppliers. The impressive CAGR of 27.34% from 2020 to 2024 highlights the growing demand for these therapies in Burkina Faso. Moreover, the remarkable growth rate of 285.37% from 2023 to 2024 signifies a significant surge in import volumes, suggesting a promising market outlook for cell gene therapy in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Cell Gene Therapy CDMO Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, 2022 & 2032F |
3.3 Burkina Faso Cell Gene Therapy CDMO Market - Industry Life Cycle |
3.4 Burkina Faso Cell Gene Therapy CDMO Market - Porter's Five Forces |
3.5 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2022 & 2032F |
3.7 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Burkina Faso Cell Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Burkina Faso Cell Gene Therapy CDMO Market Trends |
6 Burkina Faso Cell Gene Therapy CDMO Market, By Types |
6.1 Burkina Faso Cell Gene Therapy CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Viral Vector Manufacturing, 2022 - 2032F |
6.1.4 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid DNA Manufacturing, 2022 - 2032F |
6.1.5 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy Manufacturing, 2022 - 2032F |
6.1.6 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Cryopreservation Services, 2022 - 2032F |
6.2 Burkina Faso Cell Gene Therapy CDMO Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Lentiviral Vector Technology, 2022 - 2032F |
6.2.3 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid-Based Gene Delivery, 2022 - 2032F |
6.2.4 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By CAR-T Cell Expansion Technology, 2022 - 2032F |
6.2.5 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Controlled-Rate Freezing, 2022 - 2032F |
6.3 Burkina Faso Cell Gene Therapy CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2022 - 2032F |
6.3.3 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.3.4 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Hospitals and Clinics, 2022 - 2032F |
6.3.5 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Cell and Gene Therapy Developers, 2022 - 2032F |
6.4 Burkina Faso Cell Gene Therapy CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Gene Delivery for Cell Therapy, 2022 - 2032F |
6.4.3 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Preclinical and Clinical Studies, 2022 - 2032F |
6.4.4 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Oncology and Rare Diseases Treatment, 2022 - 2032F |
6.4.5 Burkina Faso Cell Gene Therapy CDMO Market Revenues & Volume, By Transport of Cell Therapies, 2022 - 2032F |
7 Burkina Faso Cell Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 Burkina Faso Cell Gene Therapy CDMO Market Export to Major Countries |
7.2 Burkina Faso Cell Gene Therapy CDMO Market Imports from Major Countries |
8 Burkina Faso Cell Gene Therapy CDMO Market Key Performance Indicators |
9 Burkina Faso Cell Gene Therapy CDMO Market - Opportunity Assessment |
9.1 Burkina Faso Cell Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Burkina Faso Cell Gene Therapy CDMO Market Opportunity Assessment, By Technology Type, 2022 & 2032F |
9.3 Burkina Faso Cell Gene Therapy CDMO Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 Burkina Faso Cell Gene Therapy CDMO Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Burkina Faso Cell Gene Therapy CDMO Market - Competitive Landscape |
10.1 Burkina Faso Cell Gene Therapy CDMO Market Revenue Share, By Companies, 2025 |
10.2 Burkina Faso Cell Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here